Medicare Enrolled

Dr. Dean Chiang, M.D.

Allergy & Immunology · Torrance, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3440 LOMITA BLVD, Torrance, CA 90505
3103263371
In practice since 2005 (20 years)
NPI: 1760484455 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chiang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chiang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chiang

Dr. Dean Chiang is an allergy & immunology specialist in Torrance, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chiang performed 10,282 Medicare services across 846 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chiang received a total of $19,162 from 36 pharmaceutical and/or device companies across 562 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chiang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 19% volume in CA $19,162 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,282
Medicare services
Top 19% in CA for allergy & immunology
846
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~514 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
5,634 $4 $10
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
1,517 $7 $11
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
1,212 $14 $19
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
447 $10 $26
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
287 $97 $166
Allergen injection administration
Professional service for the administration of a single allergen injection.
222 $8 $15
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
168 $12 $50
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
165 $58 $97
Allergy test using drug or biological combination
A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent.
132 $18 $26
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
110 $134 $293
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
93 $33 $125
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
93 $17 $60
Omalizumab injection (Xolair) for asthma/allergy 85 $0 $0
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $65 $127
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
22 $69 $70
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
22 $24 $25
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
14 $12 $45
Allergy test using ingested items, initial 2 hours
This procedure involves testing for allergies by having the patient ingest specific items over an initial two-hour period.
13 $107 $169
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,162
Total received (2018-2024)
Avg $2,737/year across 7 years
Top 15% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
562
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,415 (90.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,500 (7.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$247 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,643
2023
$3,398
2022
$2,885
2021
$1,774
2020
$2,575
2019
$1,338
2018
$4,550

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$578
GENZYME CORPORATION
$374
GlaxoSmithKline, LLC.
$341
Regeneron Healthcare Solutions, Inc.
$277
Blueprint Medicines Corporation
$184
Novartis Pharmaceuticals Corporation
$131
Optinose US, Inc.
$127
Takeda Pharmaceuticals U.S.A., Inc.
$84
PFIZER INC.
$82
Genentech USA, Inc.
$80
kaleo, Inc.
$76
BioCryst US Sales Co., LLC
$60
CSL Behring
$54
Grifols USA, LLC
$53
Phadia US Inc.
$34
Lilly USA, LLC
$31
Incyte Corporation
$24
Pharming Healthcare, Inc.
$22
Amgen Inc.
$18
ABBVIE INC.
$14
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Ironwood Pharmaceuticals, Inc
$3,375
AstraZeneca Pharmaceuticals LP
$2,734
GlaxoSmithKline, LLC.
$1,944
Amgen Inc.
$1,867
Regeneron Healthcare Solutions, Inc.
$1,117
GENZYME CORPORATION
$1,035
Novartis Pharmaceuticals Corporation
$799
PFIZER INC.
$705
Genentech USA, Inc.
$582
CSL Behring
$541
Blueprint Medicines Corporation
$454
Takeda Pharmaceuticals U.S.A., Inc.
$439
Gilead Sciences, Inc.
$352
OptiNose US, Inc.
$311
Pharming Healthcare, Inc.
$269
Optinose US, Inc.
$266
ABBVIE INC.
$228
BioCryst US Sales Co., LLC
$225
LEO Pharma Inc.
$208
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Grifols USA, LLC
$197
AbbVie Inc.
$183
kaleo, Inc.
$182
Aimmune Therapeutics, Inc.
$175
Shire North American Group Inc
$152
Incyte Corporation
$137
Kaleo, Inc.
$89
Teva Pharmaceuticals USA, Inc.
$84
Phadia US Inc.
$69
Octapharma USA, Inc.
$63
Merck Sharp & Dohme Corporation
$43
Lilly USA, LLC
$31
Horizon Therapeutics plc
$26
Intersect ENT, Inc.
$25
Merck Sharp & Dohme LLC
$25
ALK-Abello, Inc
$24
Top 3 companies account for 42.0% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINRYZE · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · EBGLYSS · EUCRISA · FARXIGA · FASENRA · Haegarda · Hizentra · ImmunoCAP · LINZESS · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · PALFORZIA · PANZYGA · ProAir Digihaler · RINVOQ · RUCONEST · SINUVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Vemlidy · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy & immunology specialist in Torrance?
Compare allergy & immunologists in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
64
Per 100K population
0.6
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chiang is a mixed practice specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chiang experienced with allergy skin test?
Based on Medicare claims data, Dr. Chiang performed 5,634 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chiang receive payments from pharmaceutical companies?
Yes. Dr. Chiang received a total of $19,162 from 36 companies across 562 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chiang's costs compare to other allergy & immunologists in Torrance?
Dr. Chiang's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chiang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →